- |||||||||| scAAV1.tMCK.NTF3 / Sarepta Therap
Trial completion date, Trial primary completion date: Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) - May 1, 2024 P1/2, N=3, Suspended, Trial completion date: Jul 2024 --> Apr 2030 | Trial primary completion date: Mar 2024 --> Apr 2028
- |||||||||| scAAV1.tMCK.NTF3 / Sarepta Therap
Trial completion date, Trial primary completion date: Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) - Mar 14, 2023 P1/2, N=3, Suspended, Trial completion date: Jul 2024 --> Apr 2030 | Trial primary completion date: Mar 2024 --> Apr 2028 Trial completion date: Jul 2023 --> Jul 2024 | Trial primary completion date: Mar 2023 --> Mar 2024
- |||||||||| scAAV1.tMCK.NTF3 / Sarepta Therap
Trial suspension: Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) - Jun 24, 2021 P1/2, N=3, Suspended, Trial completion date: Jul 2023 --> Jul 2024 | Trial primary completion date: Mar 2023 --> Mar 2024 Recruiting --> Suspended
- |||||||||| scAAV1.tMCK.NTF3 / Sarepta Therap
Trial completion date, Trial primary completion date: Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) - Feb 19, 2020 P1/2, N=9, Not yet recruiting, Not yet recruiting --> Recruiting Trial completion date: Apr 2020 --> Jul 2023 | Trial primary completion date: Apr 2020 --> Mar 2023
- |||||||||| scAAV1.tMCK.NTF3 / Sarepta Therap
Trial initiation date: Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) - Feb 20, 2019 P1/2, N=9, Recruiting, Trial completion date: Apr 2020 --> Jul 2023 | Trial primary completion date: Apr 2020 --> Mar 2023 Initiation date: Jan 2019 --> Jul 2019
|